Ticker

U.S. stock futures were mixed this morning, with the Dow futures gaining around 0.1% on Wednesday.

RENSSELAER, N.Y., June 16, 2026 (GLOBE NEWSWIRE) -- ConSynance Therapeutics, Inc. (“ConSynance”), a clinical-stage biotechnology company developing first-in-class therapies for neurobehavioral symptoms in rare neurodevelopmental disorders, today announced that the first participant has been dosed in its Phase 2a clinical trial of CSTI-500 for Prader-Willi syndrome (PWS), marking a significant clinical development…

LONDON--(BUSINESS WIRE)--The Big Six office investments reached an eight-year high in the first quarter of 2026, according to data from CoStar, a global leading provider of online real estate marketplaces, information and analytics in the property markets. Investors spent £485m across Birmingham, Bristol, Edinburgh, Glasgow, Leeds and Manchester in the first quarter of the year, slightly above the five-year average.…